SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-030358
Filing Date
2023-03-09
Accepted
2023-03-09 09:00:43
Documents
14
Period of Report
2023-03-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm238971d1_8k.htm   iXBRL 8-K 23278
2 EXHIBIT 99.1 tm238971d1_ex99-1.htm EX-99.1 8821
6 GRAPHIC tm238971d1_ex99-1img001.jpg GRAPHIC 3495
  Complete submission text file 0001104659-23-030358.txt   214435

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nviv-20230309.xsd EX-101.SCH 3063
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nviv-20230309_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nviv-20230309_pre.xml EX-101.PRE 22615
8 EXTRACTED XBRL INSTANCE DOCUMENT tm238971d1_8k_htm.xml XML 3622
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37350 | Film No.: 23718354
SIC: 3841 Surgical & Medical Instruments & Apparatus